Kliiniliste Uuringute Keskus OÜ

The medical center is at the forefront of rheumatology research, focusing on innovative treatments for conditions such as axial spondyloarthritis and psoriatic arthritis. Through rigorous clinical trials, the center evaluates the efficacy and safety of novel therapeutic agents, contributing significantly to the understanding and management of these chronic inflammatory diseases.

• Axial Spondyloarthritis
• Psoriatic Arthritis
• Rheumatoid Arthritis

By exploring the long-term effects and tolerability of treatments like filgotinib and tildrakizumab, the center aims to enhance patient outcomes and quality of life.

Specializing in the field of osteoporosis, the medical center conducts advanced research on post-menopausal osteoporosis, focusing on the efficacy and safety of biosimilar treatments. The center's work in this area is pivotal in developing therapies that improve bone mineral density and reduce fracture risk in affected populations.

• Post-Menopausal Osteoporosis
• Bone Mineral Density Improvement
• Fracture Risk Reduction

Through comparative studies of biosimilars like BP16 and established treatments, the center is advancing the field of osteoporosis treatment, ensuring accessibility and effectiveness of therapies.

The center's research in immunology is dedicated to understanding and improving treatments for autoimmune diseases such as rheumatoid arthritis. By comparing biosimilars like DRL_Tocilizumab with reference products, the center is enhancing therapeutic options and ensuring the safety and efficacy of treatments for patients with moderate to severe conditions.

• Rheumatoid Arthritis
• Biosimilar Development
• Autoimmune Disease Management

These efforts are crucial in providing patients with more effective and affordable treatment options, ultimately improving their quality of life.